Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Somesh D Sharma

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|February 3, 2009
Managing protein flexibility in docking and its applicationsChandrika B-Rao, Jyothi Subramanian, Somesh D Sharma
Metabolism: Clinical and Experimental|August 5, 2003
A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potentialDebendranath Dey, Satya Medicherla, Partha Neogi, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agentsPartha Neogi, Fredrick J Lakner, Satyanarayana Medicherla, et al.
European Journal of Pharmacology|July 13, 2010
7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammationLyle C Fonseca, Shruta S Dadarkar, Aurelio S Lobo, et al.
Metabolism: Clinical and Experimental|February 17, 2009
Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the ratLalit S Doshi, Manoja K Brahma, Sufyan G Sayyed, et al.
Inflammopharmacology|May 25, 2010
Oral bioavailability, efficacy and gastric tolerability of P2026, a novel nitric oxide-releasing diclofenac in ratAsif R Pathan, Manoj Karwa, Venu Pamidiboina, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|February 3, 2009
Managing protein flexibility in docking and its applicationsChandrika B-Rao, Jyothi Subramanian, Somesh D Sharma
Metabolism: Clinical and Experimental|August 5, 2003
A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potentialDebendranath Dey, Satya Medicherla, Partha Neogi, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agentsPartha Neogi, Fredrick J Lakner, Satyanarayana Medicherla, et al.
European Journal of Pharmacology|July 13, 2010
7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammationLyle C Fonseca, Shruta S Dadarkar, Aurelio S Lobo, et al.
Metabolism: Clinical and Experimental|February 17, 2009
Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the ratLalit S Doshi, Manoja K Brahma, Sufyan G Sayyed, et al.
Inflammopharmacology|May 25, 2010
Oral bioavailability, efficacy and gastric tolerability of P2026, a novel nitric oxide-releasing diclofenac in ratAsif R Pathan, Manoj Karwa, Venu Pamidiboina, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
Pageof 1